152
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Date seed oil loaded niosomes: development, optimization and anti-inflammatory effect evaluation on rats

ORCID Icon, , , &
Pages 1185-1197 | Received 27 Nov 2017, Accepted 30 Jan 2018, Published online: 18 Feb 2018

References

  • Chen Q, Shao X, Ling P, et al. Recent advances in polysaccharides for osteoarthritis therapy. Eur J Med Chem. 2017;139:926–935.
  • Kobayashi S, Pappas E, Fransen M, et al. The prevalence of patellofemoral osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil. 2016;24:1697–1707.
  • Scott DL, Shipley M, Dawson A, et al. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol. 1998;37:546–554.
  • Buckwalter JA, Martin JA. Osteoarthritis. Adv Drug Deliv Rev. 2006;58:150–167.
  • Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–1049.
  • Beasley J. Arthritis. 2nd ed. In: Cooper C, editor. Fundamentals of Hand Therapy: Clinical Reasoning and Treatment Guidelines for Common Diagnoses of the Upper Extremity. St. Louis (MO): Elsevier Inc.; 2014. p. 457–478.
  • Rajapakse CNA. The spectrum of rheumatic diseases in Saudi Arabia. Br J Rheumatol. 1987;26:22–23.
  • Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862:576–591.
  • Ali B, Mujeeb M, Aeri V, et al. Anti-inflammatory and antioxidant activity of Ficus carica Linn. leaves. Nat Prod Res. 2012;26:460–465.
  • Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 2000;148:187–197.
  • Mohamed D, Al-Okabi S. In vivo evaluation of antioxidant and anti-inflammatory activity of different extracts of date fruits in adjuvant arthritis. Pol J Food Nutr Sci. 2004;13:397–402.
  • Habib HM, Kamal H, Ibrahim WH, et al. Carotenoids, fat soluble vitamins and fatty acid profiles of 18 varieties of date seed oil. Ind Crops Prod. 2013;42:567–572.
  • Zhang CR, Aldosari SA, Vidyasagar PSPV, et al. Health-benefits of date fruits produced in Saudi Arabia based on in vitro antioxidant, anti-inflammatory and human tumor cell proliferation inhibitory assays. J Saudi Soc Agric Sci. 2017;16:287–293.
  • Habib HM, Ibrahim WH. Nutritional quality evaluation of eighteen date pit varieties. Int J Food Sci Nutr. 2009;60(Suppl1):99–111.
  • Ines D, Sonia B, Fatma BA, et al. Date seed oil inhibits hydrogen peroxide-induced oxidative stress in human epidermal keratinocytes. Int J Dermatol. 2010;49:262–268.
  • Nehdi I, Omri S, Khalil MI, et al. Characteristics and chemical composition of date palm (Phoenix canariensis) seeds and seed oil. Ind Crops Prod. 2010;32:360–365.
  • Besbes S, Blecker C, Deroanne C, et al. Date seed oil: phenolic, tocopherol and sterol profiles. J Food Lipids. 2004;11:251–265.
  • Zhang C-R, Aldosari SA, Vidyasagar PSPV, et al. Antioxidant and anti-inflammatory assays confirm bioactive compounds in ajwa date fruit. J Agric Food Chem. 2013;61:5834–5840.
  • Yasin BR, El-Fawal HAN, Mousa SA. Date (Phoenix dactylifera) polyphenolics and other bioactive compounds: a traditional Islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond. Int J Mol Sci. 2015;16:30075–30090.
  • Kassem MA, El-Sawy HS, Abd-Allah FI, et al. Maximizing the therapeutic efficacy of imatinib mesylate-loaded niosomes on human colon adenocarcinoma using Box–Behnken design. J Pharm Sci. 2017;106:111–122.
  • Faiyazuddin M, Akhtar N, Akhter J, et al. Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method. Pharmazie. 2010;65:348–355.
  • El-Say KM, El-Sawy HS. Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm. 2017;528:675–691.
  • Ai J, Biazar E, Jafarpour M, et al. Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine. 2011;6:1117–1127.
  • Özcan MM, AL Juhaimi F. Effect of date (Phoenix dactylifera L.) seed extract on stability of olive oil. J Food Sci Technol. 2015;52:1218–1222.
  • Wu S, Xu T, Huang D. Chemical compositions of the volatile extracts from seeds of Dendranthema nankingense and Borago officinalis. J Food Drug Anal. 2015;23:253–259.
  • Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech. 2007;8:E86.
  • Abdelbary AA, Aboughaly MHH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485:235–243.
  • El-Say KM, Abd-Allah FI, Lila AE, et al. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J Liposome Res. 2016;26:57–68.
  • Yeom S, Shin BS, Han S. An electron spin resonance study of non-ionic surfactant vesicles (niosomes). Chem Phys Lipids. 2014;181:83–89.
  • Marianecci C, Rinaldi F, Di Marzio L, et al. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. Int J Nanomed. 2014;9:635–651.
  • Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm. 2002;231:21–32.
  • Hashim F, El-Ridy M, Nasr M, et al. Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug Deliv. 2010;17:282–287.
  • Besbes S, Blecker C, Deroanne C, et al. Date seeds: chemical composition and characteristic profiles of the lipid fraction. Food Chem. 2004;84:577–584.
  • El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77:43–55.
  • Ahmed TA, El-Say KM, Aljaeid BM, et al. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: preparation, characterization, in vitro, ex vivo and clinical evaluation. Int J Pharm. 2016;500:245–254.
  • Zhang Y, Zhang K, Wu Z, et al. Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake. Int J Pharm. 2015;478:138–146.
  • Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 2009;133:11–17.
  • Jana U, Mohanty AK, Pal SL, et al. Felodipine loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo toxicity study. Nano Converg. 2014;1:31.
  • Abaee A, Madadlou A. Niosome-loaded cold-set whey protein hydrogels. Food Chem. 2016;196:106–113.
  • Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release. 2012;164:17–25.
  • Yuksel N, Bayindir ZS, Aksakal E, et al. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: in vitro and in vivo evaluations. Int J Biol Macromol. 2016;82:453–463.
  • Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740–747.
  • El-Ridy MS, Abdelbary A, Essam T, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm. 2011;37:1491–1508.
  • Souza MHLP, Mota JMSC, Oliveira RB, et al. Gastric damage induced by different doses of indomethacin in rats is variably affected by inhibiting iNOS or leukocyte infiltration. Inflamm Res. 2008;57:28–33.
  • Sarkhel S. Evaluation of the anti-inflammatory activities of Quillaja saponaria Mol. saponin extract in mice. Toxicol Reports. 2016;3:1–3.
  • Tatiya AU, Saluja AK, Kalaskar MG, et al. Evaluation of analgesic and anti-inflammatory activity of Bridelia retusa (Spreng) bark. J Tradit Complement Med. 2017;7:441–451.
  • Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–547.
  • Bendas ER, Abdullah H, El-Komy MHM, et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm. 2013;458:287–295.
  • Garg NK, Tyagi RK, Bhupinder S, et al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-Kb and FOXO1. Int J Pharm. 2016;499:301–320.
  • Drummondy DC, Hayes ME, Noble CO IV, et al. Intraliposomal trapping agents for improving in vivo liposomal drug formulation stability. 3rd ed. In: Gregoriadis G, editor. Liposome Technology. New York (NY): Informa Healthcare USA Inc; 2007. p. 149–168.
  • Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes: drug entrapment, stability and release. J Microencapsul. 1987;4:321–328.
  • Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
  • Waddad AY, Abbad S, Yu F, et al. Formulation, characterization and pharmacokinetics of morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm. 2013;456:446–458.
  • Sahoo RK, Biswas N, Guha A, et al. Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide – maltodextrin complex. Acta Pharm Sin B. 2014;4:1–9.
  • El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006;308:140–148.
  • Pezeshky A, Ghanbarzadeh B, Hamishehkar H, et al. Vitamin A palmitate-bearing nanoliposomes: preparation and characterization. Food Biosci. 2016;13:49–55.
  • Arunothayanun P, Bernard MS, Craig DQM, et al. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm. 2000;201:7–14.
  • Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci. 2016;11:404–416.
  • Mao S, Shi Y, Li L, et al. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm. 2008;68:214–223.
  • Guinedi AS, Mortada ND, Mansour S, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71–82.
  • El-Nabarawi MA, Bendas ER, El Rehem RTA, et al. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm. 2013;443:307–317.
  • Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1:208–219.
  • Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11:1119–1127.
  • Abdelkader H, Ismail S, Kamal A, et al. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;99:1833–1846.
  • Mehta SK, Jindal N. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloids Surf B Biointerfaces. 2013;101:434–441.
  • Shenoy VS, Gude RP, Murthy RS. In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines. Int Nano Lett. 2013;3:36.
  • Marianecci C, Paolino D, Celia C, et al. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release. 2010;147:127–135.
  • Mahmoudi Najafi SH, Baghaie M, Ashori A. Preparation and characterization of acetylated starch nanoparticles as drug carrier: ciprofloxacin as a model. Int J Biol Macromol. 2016;87:48–54.
  • Kumar S, Sangwan P, Lather V, et al. Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol. J Drug Deliv Sci Technol. 2015;30:54–62.
  • Marianecci C, Di L, Rinaldi F, et al. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 2014;205:187–206.
  • Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–820.
  • Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20:87–103.
  • Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188:21–28.
  • Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: novel sustained release nonionic stable vesicular systems – An overview. Adv Colloid Interface Sci. 2012;183–184:46–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.